PRF Technologies Ltd. (PainReform Ltd.) Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated August 13, 2024, reports on the Extraordinary General Meeting of Shareholders held on the same date. The registrant, PainReform Ltd., is a foreign private issuer based in Tel Aviv, Israel, filing under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and does not contain financial statements or performance data.
Material Changes
The primary material event reported is the shareholder approval of seven proposals presented at the Extraordinary General Meeting. All proposals were approved in accordance with the required majority. Details of these proposals were previously disclosed in the Notice and Proxy Statement dated July 9, 2024.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document serves solely to confirm the outcome of the shareholder vote.
Key Facts for Investor Verification
- All seven proposals presented at the August 13, 2024, Extraordinary General Meeting were approved by shareholders.
- Specific details of the approved proposals are located in the Notice and Proxy Statement filed on July 9, 2024 (Exhibit 99.1).
- Ehud Geller signed the report in his capacity as Interim Chief Executive Officer.
- No financial performance data is included in this specific filing.